Two Sigma Securities’s Ensysce Biosciences ENSC Stock Holding History

Two Sigma Securities’s Portfolio ENSC Stock Details ENSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,605	Closed	-$19.9K	–	1785
2025 Q4	$19.9K	Buy	+21,605	New	+$40.1K	﹤0.01%	1183
2023 Q4	–	Sell	-974	Closed	-$20.2K	–	3165
2023 Q3	$20.2K	Buy	+974	New	+$27.6K	﹤0.01%	2569
2022 Q4	–	Sell	-9	Closed	-$7K	–	2749
2022 Q3	$7K	Buy	9 +2	+29%	+$3.26K	﹤0.01%	2443
2022 Q2	$21K	Buy	+7	New	+$19.6K	﹤0.01%	1952
2021 Q4	–	Sell	-3	Closed	-$34K	–	1668
2021 Q3	$34K	Buy	+3	New	+$58.6K	﹤0.01%	1419

Other funds holding ENSC

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TIAM2

Tru Independence Asset Management 2 Portland, Oregon $163M AUM 18.06% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Securities's ENSC Position: Q1 2026 in Review

Two Sigma Securities sold out of Ensysce Biosciences (ENSC) in Q1 2026, closing a stake of 21,605 shares — an estimated $19.9K sold.

Two Sigma Securities first reported a position in ENSC in Q3 2021 and held it in 5 quarters. The position peaked at $34K in Q3 2021. 15 funds tracked by Wall St. Rank hold ENSC as of Q1 2026.

Two Sigma Securities reported no remaining Ensysce Biosciences position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 21,605 Ensysce Biosciences shares in Q1 2026, an estimated $19.9K.
Two Sigma Securities first reported a position in Ensysce Biosciences in Q3 2021 and held it in 5 quarters.
Two Sigma Securities's Ensysce Biosciences position peaked at $34K in Q3 2021.
15 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.